Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: nezahualcoyotl2012 / Re: Why the 5% additional dilution since the 10K filing?!

Keep in mind the PTSC reported roughly 387M shares outstanding on August 8 and 407M outstanding on August 29. In between, to my knowledge, there were no announcements that would account for the 20M share increase. Whether those shares came from the treasury or not has not been disclosed as far as I can tell.

2
Sep 15, 2008 10:06AM
Share
New Message
Please login to post a reply